About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Arizona | 705 Studies

Clinical Trials Breast CancerArizona

Breast Cancer Clinical Trials in Arizona

Find 705 clinical trials for breast cancer near Arizona. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 705 trials

Active not recruitingStudy of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast CancerThe primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) versus treatment of physician's choice (TPC) in…NCT05382299·Tucson, Arizona and 362 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingThe OPBC-07/microNAC StudyThe aim of this multicenter retrospective cohort study is to determine the safety of omission of axillary lymph node dissection in patients with residual micrometastases after…NCT06529302·Phoenix, Arizona and 83 others

CompletedA Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast CancerTo demonstrate whether addition of MM-121 to paclitaxel is more effective than treatment with paclitaxel alone, when administered as part of the neoadjuvant treatment in Her2…NCT01421472·Birmingham, Alabama and 37 others

CompletedStereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerThis phase I trial studies the side effects and the best dose of stereotactic body radiation therapy in treating patients with breast cancer, non-small cell lung cancer, or…NCT02206334·Birmingham, Alabama and 77 others

CompletedGinseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer SurvivorsThis randomized pilot trial studies how well North American ginseng extract AFX-2 (ginseng) works in decreasing cancer-related fatigue after treatment in cancer survivors.NCT03407716·Scottsdale, Arizona

CompletedAn Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)This multi-center, prospective observational study will evaluate the treatment patterns, and the safety in patients with HER2-positive (HER2+) metastatic breast cancer (MBC).NCT01615068·Birmingham, Alabama and 141 others

Completed⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's LymphomaTo determine the safety and feasibility of 89Zr-Df-IAB22M2C as an immunoPET tracer; determine the best time window and protein dose for imaging; determine the pharmacokinetic (PK)…NCT03107663·Scottsdale, Arizona and 2 others

Active not recruitingEndocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast CancerThe purpose of this study is to evaluate the safety and efficacy of the study drug abemaciclib in participants with high risk, node positive, early stage, hormone receptor…NCT03155997·Birmingham, Alabama and 618 others

RecruitingPhase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerThe purpose of this research study is to compare the effects (good and bad) on women and their cancer using proton radiation therapy.NCT01766297·Scottsdale, Arizona and 8 others

TerminatedRTX-224 Monotherapy in Patients With Solid TumorsThis is an open-label, multidose, first-in-human (FIH), Phase 1/2 study of RTX-224 for the treatment of patients with relapsed or refractory (R/R), or locally advanced solid…NCT05219578·Scottsdale, Arizona and 4 others

Active not recruitingS0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast CancerRATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamide, and paclitaxel, use different ways to stop tumor cells from dividing so they stop growing or die.NCT00070564·Anniston, Alabama and 541 others

CompletedExercise Preconditioning and Breast Cancer CardiotoxicityThe purpose of this study is to determine whether a supervised exercise-training program, initiated prior to chemotherapy induction (pre-conditioning) and continued throughout…NCT02842658·Scottsdale, Arizona

CompletedA Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-CisplatinThe purpose of this study is to investigate the pharmacokinetics (PK) of necitumumab in combination with gemcitabine-cisplatin in participants with advanced malignant solid tumors…NCT01606748·Scottsdale, Arizona and 3 others

RecruitingRibociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast CancerThis is an open label, multicenter, single arm phase II study to evaluate the efficacy and safety of ribociclib and ET in patients with locoregional recurrence of HR-positive…NCT05467891·Birmingham, Alabama and 20 others

TerminatedPF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid TumorsThe study will evaluate the safety, pharmacokinetics and pharmacodynamics of increasing doses of PF-06804103 in patients with HER2 positive and negative breast and gastric cancer…NCT03284723·Tucson, Arizona and 45 others

UnknownTPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and SurgeryThis phase II trial studies how well TPIV100 and sargramostim work in treating patients with HER2 positive, stage II-III breast cancer that has residual disease after chemotherapy…NCT04197687·Scottsdale, Arizona and 29 others

CompletedStudy of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast CancerThe primary purpose of this study was to assess the efficacy of ribociclib, as measured by progression free survival (PFS), in postmenopausal women with hormone receptor positive…NCT01958021·Chandler, Arizona and 220 others

TerminatedPhase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast CancerThis study is a multi-center, randomized, double-blind, placebo-controlled, Phase 2 study in postmenopausal women with heregulin positive, hormone receptor positive, HER2 negative…NCT03241810·Chandler, Arizona and 58 others

RecruitingPhase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067This is a multiphase, multicenter study, which includes a Phase 1a open-label, dose escalation monotherapy study of ST-067 given as an SC injection with or without obinutuzumab…NCT04787042·Scottsdale, Arizona and 5 others

CompletedFulvestrant and Bevacizumab in Treating Patients With Metastatic Breast CancerRATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using fulvestrant may fight breast cancer by blocking the use of estrogen by the tumor cells.NCT00423917·Scottsdale, Arizona and 204 others

PreviousPage 5 of 36Next

Other Conditions in Arizona

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma